-- Robert Preidt
FRIDAY, Oct. 28 (HealthDay News) -- Many Alzheimer's patients
who take cholinesterase inhibitors to slow their brain disease also
take drugs that counter the effects of those Alzheimer's
medications, a new study says.
Clinical trials have shown that cholinesterase inhibitors such
as Aricept (donepezil) have a modest impact on the functional and
cognitive decline caused by Alzheimer's disease, noted the
researchers at the Group Health Research Institute in Seattle.
"Cholinesterase inhibitors are today's primary therapy for slowing Alzheimer's disease," study leader Denise Boudreau said in an institute news release.
"Anticholinergic properties are often found in drugs commonly used to treat gastrointestinal disorders, allergies, urinary incontinence, depression and Parkinson's disease, and they can have negative effects on cognition and function in the elderly. There's concern that if someone is taking both types of drugs -- cholinesterase inhibitors and anticholinergic medications -- they will antagonize each other, and neither will work," she explained.
Common anticholinergic medications include Benadryl
(diphenhydramine) and Ditropan (oxybutynin), which is prescribed
for overactive bladders.
Boudreau and colleagues analyzed data from more than 5,600
patients aged 50 and older who had cholinesterase inhibitors
prescribed to them for the first time between 2000 and 2007. Of
those patients, 37 percent also took at least one anticholinergic
drug and more than 11 percent took two or more anticholinergic
Among the patients who took both classes of drugs, dual use
generally lasted three to four months, but one-quarter of the
patients used both classes of drugs for more than a year.
The researchers also found that 23 percent of patients who
received a new prescription for cholinesterase inhibitors were
already using at least one anticholinergic drug, and 77 percent of
those patients continued taking an anticholinergic drug after they
began taking a cholinesterase inhibitor.
"It's reassuring that we did not observe an association between simultaneous use of the two types of drugs and increased risk of death or nursing home placement," Boudreau said in the release. "But concomitant use of these drugs is, at the very least, not optimal clinical practice."
The study was published online Oct. 22 in the
Journal of the American Geriatrics Society.
Alzheimer's patients often have multiple health problems, which
may help explain why doctors might prescribe conflicting
medications for these patients, the researchers said.
The U.S. National Institute on Aging has more about
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.